相关实验视频
Updated: Jun 16, 2025

06:33
Production of Human CRISPR-Engineered CAR-T Cells
Published on: March 15, 2021
12.9K
精确瘤学革命:CRISPR-Cas9和PROTAC技术得到了释放
Karim Kanbar1,2, Roy El Darzi1,2, Diana E Jaalouk2
1Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
Frontiers in genetics
|August 15, 2024
概括
精确瘤学在CRISPR基因编辑和PROTAC向蛋白质降解方面取得了进展. 这些技术通过精确准基因突变和蛋白质降解,为抗击癌症提供了新的途径,在临床试验中显示出有希望的结果.
科学领域:
- 在瘤学瘤学.
- 生物技术是生物技术.
- 遗传学 遗传学 是一个
背景情况:
- 癌症仍然是一个重大的全球健康挑战,需要创新的治疗策略.
- 精确瘤学旨在准癌症的特定分子驱动因素,提高疗效和减少副作用.
- 传统疗法经常与"无法治疗"的标和非标毒性作斗争.
研究的目的:
- 在精密瘤学中审查CRISPR-Cas9基因编辑和PROTAC向蛋白质降解的现状和临床影响.
- 为了比较CRISPR和PROTAC技术的设计,潜力和局限性.
- 探索结合这些突破性的方法的协同潜力.
主要方法:
- 审查CRISPR-Cas9基因编辑技术用于精确的DNA修饰.
- 对针对性蛋白质降解的PROTAC (PROteolysis TTargeting Chimeras) 技术进行审查.
- 对癌症治疗中两种技术的临床前和临床试验数据的分析.
主要成果:
- 克里斯普尔-Cas9提供精确,高效和适应性的基因修饰,具有诊断潜力.
- PROTACs提供可口服的,组织特异性的蛋白质降解,具有广泛的向能力.
- 这两种技术在临床前研究和有希望的临床试验数据中都显示出显著的潜力.
结论:
- 克里斯普尔和普罗塔克技术代表了精密瘤学的革命性进步.
- 它们的应用取决于上下文,基于癌症的特定分子机制.
- 这些互补的技术具有协同利用的潜力,扩大治疗选择.
相关概念视频
CRISPR
50.0K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.0K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Homologous Recombination
50.3K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.3K
CRISPR and crRNAs
16.9K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.9K

